Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
Background: A fundamental question in Alzheimer’s disease (AD) is whether amyloid-β (Aβ) peptides and their deposition in the brain signify a direct pathological role or they are mere outcome of the disease pathophysiological events affecting neuronal function. It is therefore important to decipher...
Main Authors: | Erica Lana, Anna Gellerbring, Sabrina Jung, Agneta Nordberg, Christina Unger Lithner, Taher Darreh-Shori |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2019.00176/full |
Similar Items
-
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ε4 allele, in relation to cognitive function and cerebral glucose metabolism
by: T. Darreh-Shori, et al.
Published: (2006-11-01) -
Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
by: Roger M. Lane, et al.
Published: (2024-04-01) -
Symmetry versus Asymmetry in the Molecules of Life: Homomeric Protein Assemblies
by: Biserka Kojić-Prodić, et al.
Published: (2010-04-01) -
Subcellular Localization of Homomeric TASK3 Channels and Its Presumed Functional Significances in Trigeminal Motoneurons
by: Mitsuru Saito, et al.
Published: (2022-12-01) -
CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment
by: Azadeh Karami, et al.
Published: (2021-08-01)